These additional pathways are not workarounds they are legitimate FDA-approved indications
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
The single-payer public system, generic semaglutide approval, patent lapse due to missed maintenance fee, the presence of provincial supply protection laws, reimbursement models for obesity indication, and comprehensive societal value modeling are certain factors that are driving the semaglutide market in Canada
However, it's important to understand that the true essence of our program lies in long-term success
The dosing schedule, titration timeline, and expected responses differ significantly
Many NexLife members report noticing reduced appetite within the first 12 weeks